limited – Lab DB

Pharmaceutical R&D

Gilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies

Teuku Ryan Mar 20, 2026 0

The Netherlands faces significant challenges in ensuring timely patient access to life-changing advanced therapy medicinal products (ATMPs), a situation exacerbated…

Gilead Executive Sounds Alarm on Limited Innovation Investment Hindering Access to Advanced Therapies

YOU MAY HAVE MISSED

Breakthrough in Male Contraception: Cornell Scientists Identify Nonhormonal Pathway to Reversible Infertility via Meiotic Interruption

The Quest for Monoclonality: Sartorius Infographic Illuminates Next-Generation Solutions for Cell-Line Development

Immuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure Throughput

Mental Sharpness and Daily Productivity Gains Quantified in New University of Toronto Study